AL
UTHR icon

AJO LP’s United Therapeutics UTHR Stock Holding History

AJO LP’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-21,793
Closed -$3.31M – 242
2020
Q4 		$3.31M Sell
21,793
-225,167
-91% -$29.5M 0.34% 101
2020
Q3 		$24.9M Buy
246,960
+98,326
+66% +$10.8M 0.26% 110
2020
Q2 		$18M Buy
148,634
+14,401
+11% +$1.62M 0.16% 140
2020
Q1 		$12.7M Sell
134,233
-94,497
-41% -$8.98M 0.11% 181
2019
Q4 		$20.1M Buy
+228,730
New +$20.1M 0.12% 161
2019
Q1 		– Sell
-75,646
Closed -$8.24M – 749
2018
Q4 		$8.24M Buy
75,646
+11,002
+17% +$1.28M 0.05% 250
2018
Q3 		$8.27M Buy
64,644
+58,119
+891% +$7.19M 0.04% 265
2018
Q2 		$738K Buy
+6,525
New +$717K ﹤0.01% 550
2017
Q3 		– Sell
-829,259
Closed -$108M – 619
2017
Q2 		$108M Sell
829,259
-860,053
-51% -$107M 0.46% 72
2017
Q1 		$229M Sell
1,689,312
-307,013
-15% -$46.5M 0.95% 39
2016
Q4 		$286M Sell
1,996,325
-95,240
-5% -$12.2M 1.18% 19
2016
Q3 		$247M Sell
2,091,565
-49,976
-2% -$6M 1.06% 28
2016
Q2 		$227M Buy
2,141,541
+258,931
+14% +$28.9M 1.01% 29
2016
Q1 		$210M Buy
1,882,610
+401,675
+27% +$50.8M 0.91% 36
2015
Q4 		$232M Buy
1,480,935
+252,565
+21% +$36.8M 1.01% 27
2015
Q3 		$161M Buy
1,228,370
+25,070
+2% +$4.02M 0.74% 45
2015
Q2 		$209M Sell
1,203,300
-72,890
-6% -$13.1M 0.89% 37
2015
Q1 		$220M Sell
1,276,190
-280,420
-18% -$42.8M 0.92% 36
2014
Q4 		$202M Sell
1,556,610
-304,780
-16% -$39.3M 0.85% 45
2014
Q3 		$239M Sell
1,861,390
-199,570
-10% -$20.6M 1.06% 31
2014
Q2 		$182M Sell
2,060,960
-97,290
-5% -$9.36M 0.78% 53
2014
Q1 		$203M Sell
2,158,250
-101,410
-4% -$10.4M 0.89% 57
2013
Q4 		$256M Buy
2,259,660
+18,190
+0.8% +$1.64M 1.12% 25
2013
Q3 		$177M Buy
2,241,470
+238,300
+12% +$17.4M 0.8% 55
2013
Q2 		$132M Buy
+2,003,170
New +$129M 0.61% 59

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

AJO LP's UTHR Position: Q1 2021 in Review

AJO LP sold out of United Therapeutics (UTHR) in Q1 2021, closing a stake of 21,793 shares — an estimated $3.31M sold.

AJO LP first reported a position in UTHR in Q2 2013 and held it in 25 quarters. The position peaked at $286M in Q4 2016. 391 funds tracked by Wall St. Rank hold UTHR as of Q1 2021.

  • AJO LP reported no remaining United Therapeutics position as of Q1 2021 after selling out during the quarter.
  • AJO LP sold 21,793 United Therapeutics shares in Q1 2021, an estimated $3.31M.
  • AJO LP first reported a position in United Therapeutics in Q2 2013 and held it in 25 quarters.
  • AJO LP's United Therapeutics position peaked at $286M in Q4 2016.
  • 391 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2021.

Based on AJO LP's 13F filing for Q1 2021, filed 7 May 2021.